We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

127 hedge funds and large institutions have $521M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 133 → 127 (-6)

13% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 39

18% less capital invested

Capital invested by funds: $633M → $521M (-$112M)

39% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 44

87% less call options, than puts

Call options by funds: $280K | Put options by funds: $2.15M

Holders
127
Holders Change
-6
Holders Change %
-4.51%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
34
Increased
27
Reduced
44
Closed
39
Calls
$280K
Puts
$2.15M
Net Calls
-$1.87M
Net Calls Change
+$531K

Top Buyers

1
Invesco
Invesco
Georgia
+$16.9M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$11.6M
3
Millennium Management
Millennium Management
New York
+$11.2M
4
MWNA
Marshall Wace North America
New York
+$9.02M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.34M

Top Sellers

1
BlackRock
BlackRock
New York
-$53.6M
2
MICM
Matthews International Capital Management
California
-$22.7M
3
State Street
State Street
Massachusetts
-$21.9M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$14.9M
5
Goldman Sachs
Goldman Sachs
New York
-$7.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
76
Barclays
United Kingdom
$318K -$2.21M -20,134 -87%
TRCT
77
Tower Research Capital (TRC)
New York
$314K +$210K +1,913 +177%
PM
78
Parametrica Management
Hong Kong
$306K +$322K +2,927 New
Capstone Investment Advisors
79
Capstone Investment Advisors
New York
$303K +$319K +2,900 New
SG Americas Securities
80
SG Americas Securities
New York
$271K -$267K -2,434 -48%
SC
81
Scotia Capital
Ontario, Canada
$265K +$278K +2,530 New
AIM
82
ARK Investment Management
Florida
$247K +$259K +2,356 New
CPH
83
C Partners Holding
Switzerland
$244K +$256K +2,334 New
WAM
84
World Asset Management
Michigan
$242K -$10.4K -95 -4%
Comerica Bank
85
Comerica Bank
Texas
$230K -$36.3K -330 -13%
Bessemer Group
86
Bessemer Group
New Jersey
$226K +$6.04K +55 +3%
EM
87
ELCO Management
New York
$223K – – –
ANI
88
American National Insurance
Texas
$217K – – –
Balyasny Asset Management
89
Balyasny Asset Management
Illinois
$217K +$228K +2,072 New
DTL
90
Dynamic Technology Lab
Singapore
$210K +$221K +2,008 New
BNP Paribas Financial Markets
91
BNP Paribas Financial Markets
France
$182K – – –
PAM
92
Panagora Asset Management
Massachusetts
$155K -$4.9M -44,567 -97%
ASN
93
Advisory Services Network
Georgia
$119K -$211K -1,920 -63%
Bank of Montreal
94
Bank of Montreal
Ontario, Canada
$107K -$124K -1,126 -52%
US Bancorp
95
US Bancorp
Minnesota
$102K -$50.2K -457 -32%
CG
96
Cutler Group
California
$94K +$87.9K +800 +800%
CCM
97
Covington Capital Management
California
$79K – – –
Wells Fargo
98
Wells Fargo
California
$63K -$125K -1,134 -65%
Citigroup
99
Citigroup
New York
$56K -$445K -4,052 -88%
Macquarie Group
100
Macquarie Group
Australia
$42K – – –
2 3
4
5 6

TARO Hedge Fund Activity: Q4 2017 in Review

127 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2017, worth a combined $521M — down 18% from $633M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of TARO and 34 opened new positions — a net loss of 5 holders — while 44 trimmed existing stakes and 27 added.

The largest buyer was Invesco, adding an estimated $16.9M. The largest seller was BlackRock, cutting an estimated $53.6M.

  • 127 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2017, down from 133 in Q3 2017.
  • Funds reported $521M of Taro Pharmaceutical Industries Ltd. stock for Q4 2017, down 18% quarter-over-quarter.
  • 34 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2017 and 39 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2017 was Invesco, an estimated $16.9M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2017 was BlackRock, an estimated $53.6M sold.

Based on aggregated 13F filings for Q4 2017.